4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-21-009083
President and CEO sold 50,985 shares at an average $71.70 ($3,655,410)
- President and CEO acquired 96,718 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LEONARD JOHN M · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 1 in the form | +40,000 | $13.40 | $536,000 | 654,803 | D |
| 2021-02-05 | Sale : show line 2 in the form | −8,043 | $67.18 | $540,329 | 646,760 | D |
| 2021-02-05 | Sale : show line 3 in the form | −14,018 | $67.86 | $951,261 | 632,742 | D |
| 2021-02-05 | Sale : show line 4 in the form | −881 | $68.78 | $60,595 | 631,861 | D |
| 2021-02-09 | Exercise or conversion : show line 5 in the form | +56,718 | $6.83 | $387,384 | 688,579 | D |
| 2021-02-09 | Sale : show line 6 in the form | −28,043 | $75.00 | $2,103,225 | 660,536 | D |
| Open-market sales · 50,985 sh · avg $71.70 · $3,655,410 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-05 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −40,000 | 285,453 | D |
| 2021-02-09 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −56,718 | 68,516 | D |
Loading xslF345X03/doc4.xml…